Erin Duffy

Erin Duffy is the Chief of Research & Development at CARB-X. CARB-X is a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat bacterial infections. Most of her professional growth was with Melinta Therapeutics (founded as Rib-X Pharmaceuticals) where over 17 years she became EVP, Chief Scientific Officer and R&D site head. Prior to Melinta, Erin led a structure-based design team at Achillion Pharmaceuticals and was a research scientist at Pfizer Central Research. Erin’s formal training was at Yale University, where she completed a PhD in physical-organic chemistry and an HHMI postdoctoral fellowship in computational structural biology.